New hope for toddlers with sickle cell: liquid medicine study aims to prevent painful crises

NCT ID NCT06923111

Recruiting now Disease control Sponsor: Nova Laboratories Limited Source: ClinicalTrials.gov ↗

Summary

This study is checking the safety and real-world effectiveness of a liquid medicine called Xromi for very young children with sickle cell disease. It will follow about 180 children under 2 years old for two years, comparing those taking the medicine to similar children who are not. The main goal is to see if the medicine helps prevent painful complications and to monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Basildon University Hospital
RECRUITING

Basildon, United Kingdom
Evelina London Children's Hospital
RECRUITING

London, United Kingdom
John Radcliffe Hospital
RECRUITING

Oxford, United Kingdom
Kings College Hospital
RECRUITING

London, United Kingdom
Noah's Ark Children's Hospital for Wales
RECRUITING

Cardiff, United Kingdom
North Middlesex University Hospital
RECRUITING

London, United Kingdom
Royal Manchester Children's Hospital
RECRUITING

Manchester, United Kingdom
The Royal London Hospital
RECRUITING

London, United Kingdom
University College London Hospital
RECRUITING

London, United Kingdom
Universitätsklinikum Hamburg-Eppendorf
RECRUITING

Hamburg, Germany
Universitätsklinikum Heidelberg
RECRUITING

Heidelberg, Germany
Whittington Hospital
RECRUITING

London, United Kingdom

Conditions

Explore the condition pages connected to this study.

SICKLE CELL DISEASE